Portunus trituberculatus isolate SZX2019 chromosome 28, ASM1759143v1, whole genome shotgun sequence.
Portunus trituberculatus (swimming crab)
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Crustacea; Multicrustacea; Malacostraca; Eumalacostraca; Eucarida; Decapoda; Pleocyemata; Brachyura; Eubrachyura; Portunoidea; Portunidae; Portunus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM030098.1.\nAssembly name: ASM1759143v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Center for Ecological and\nEnvironmental Sciences on 2021/03/30. The original whole-genome\nshotgun project has the accession JAGGDN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Center for Ecological and Environmental\n Sciences\nAssembly Method :: Wtdbg v. 2.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 54.74x\nSequencing Technology :: Oxford Nanopore; Illumina\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Portunus trituberculatus Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC123510036, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC123510036, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized protein LOC123510036 isoform X1
uncharacterized protein LOC123510036 isoform X2
sentrin-specific protease 1-like, transcript variant X4
COORDINATES: polyA evidence [ECO:0006239]
sentrin-specific protease 1-like, transcript variant X3
sentrin-specific protease 1-like, transcript variant X5
sentrin-specific protease 1-like, transcript variant X2
sentrin-specific protease 1-like, transcript variant X1
sentrin-specific protease 1-like isoform X4
sentrin-specific protease 1-like isoform X3
sentrin-specific protease 1-like isoform X1
sentrin-specific protease 1-like isoform X5
sentrin-specific protease 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
protein turtle-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein turtle-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X1
basement membrane-specific heparan sulfate proteoglycan core protein-like, transcript variant X2
basement membrane-specific heparan sulfate proteoglycan core protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123510051, transcript variant X1
uncharacterized LOC123510051, transcript variant X3
uncharacterized LOC123510051, transcript variant X2
X-ray repair cross-complementing protein 5-like, transcript variant X1
X-ray repair cross-complementing protein 5-like isoform X1
X-ray repair cross-complementing protein 5-like, transcript variant X2
X-ray repair cross-complementing protein 5-like isoform X2
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X6
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X2
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X1
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X4
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X3
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X5
5-phosphohydroxy-L-lysine phospho-lyase-like, transcript variant X7
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X3
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X1
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X4
5-phosphohydroxy-L-lysine phospho-lyase-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X6
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X7
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X8
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X4
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X5
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X6
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X1
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X3
aldehyde dehydrogenase, dimeric NADP-preferring-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nascent polypeptide-associated complex subunit alpha, muscle-specific form-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: nascent polypeptide-associated complex subunit alpha, muscle-specific form-like
protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha-like
thioredoxin domain-containing protein 9-like, transcript variant X2
thioredoxin domain-containing protein 9-like, transcript variant X1
thioredoxin domain-containing protein 9-like
probable phospholipid-transporting ATPase IIB, transcript variant X6
probable phospholipid-transporting ATPase IIB, transcript variant X7
probable phospholipid-transporting ATPase IIB, transcript variant X5
probable phospholipid-transporting ATPase IIB, transcript variant X3
probable phospholipid-transporting ATPase IIB, transcript variant X9
probable phospholipid-transporting ATPase IIB, transcript variant X2
probable phospholipid-transporting ATPase IIB, transcript variant X10
probable phospholipid-transporting ATPase IIB, transcript variant X8
probable phospholipid-transporting ATPase IIB, transcript variant X1
probable phospholipid-transporting ATPase IIB, transcript variant X4
probable phospholipid-transporting ATPase IIB, transcript variant X11
probable phospholipid-transporting ATPase IIB isoform X5
probable phospholipid-transporting ATPase IIB isoform X3
probable phospholipid-transporting ATPase IIB isoform X2
probable phospholipid-transporting ATPase IIB isoform X1
probable phospholipid-transporting ATPase IIB isoform X4
probable phospholipid-transporting ATPase IIB isoform X6
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X6
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X2
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X1
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X5
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X4
N-acetylglucosamine-6-phosphate deacetylase-like, transcript variant X3
N-acetylglucosamine-6-phosphate deacetylase-like
heparan sulfate 2-O-sulfotransferase pipe-like, transcript variant X2
heparan sulfate 2-O-sulfotransferase pipe-like, transcript variant X3
heparan sulfate 2-O-sulfotransferase pipe-like, transcript variant X1
heparan sulfate 2-O-sulfotransferase pipe-like isoform X1
heparan sulfate 2-O-sulfotransferase pipe-like isoform X2
heparan sulfate 2-O-sulfotransferase pipe-like isoform X3
interference hedgehog-like, transcript variant X2
interference hedgehog-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 41 member 1-like, transcript variant X5
solute carrier family 41 member 1-like, transcript variant X1
solute carrier family 41 member 1-like, transcript variant X2
solute carrier family 41 member 1-like, transcript variant X4
solute carrier family 41 member 1-like, transcript variant X3
solute carrier family 41 member 1-like isoform X1
solute carrier family 41 member 1-like isoform X2
solute carrier family 41 member 1-like isoform X4
solute carrier family 41 member 1-like isoform X3
probable rhodanese domain-containing dual specificity protein phosphatase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
dual serine/threonine and tyrosine protein kinase-like
prefoldin subunit 4-like, transcript variant X3
prefoldin subunit 4-like, transcript variant X1
prefoldin subunit 4-like, transcript variant X2
G patch domain-containing protein 8-like, transcript variant X3
G patch domain-containing protein 8-like, transcript variant X1
uncharacterized protein LOC123510239 isoform X1
uncharacterized protein LOC123510239 isoform X3
G patch domain-containing protein 8-like, transcript variant X2
G patch domain-containing protein 8-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF14-like, transcript variant X3
E3 ubiquitin-protein ligase RNF14-like, transcript variant X4
E3 ubiquitin-protein ligase RNF14-like, transcript variant X2
E3 ubiquitin-protein ligase RNF14-like, transcript variant X1
E3 ubiquitin-protein ligase RNF14-like isoform X1
E3 ubiquitin-protein ligase RNF14-like isoform X2
tyrosine-protein phosphatase non-receptor type 23-like
LOW QUALITY PROTEIN: tyrosine-protein phosphatase non-receptor type 23-like
fatty acid synthase-like, transcript variant X1
fatty acid synthase-like, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein unc-13 homolog A-like
uncharacterized LOC123510219, transcript variant X1
uncharacterized LOC123510219, transcript variant X3
uncharacterized LOC123510219, transcript variant X2
uncharacterized protein LOC123510219 isoform X1
uncharacterized protein LOC123510219 isoform X3
uncharacterized protein LOC123510219 isoform X2
LOW QUALITY PROTEIN: laminin subunit alpha-1-like
uncharacterized LOC123510007, transcript variant X4
uncharacterized LOC123510007, transcript variant X2
uncharacterized LOC123510007, transcript variant X3
uncharacterized LOC123510007, transcript variant X5
uncharacterized LOC123510007, transcript variant X1
guanine nucleotide-binding protein G(s) subunit alpha-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
LOW QUALITY PROTEIN: ras-related protein Rab-27A-like
ubiquitin carboxyl-terminal hydrolase 30-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin carboxyl-terminal hydrolase 30-like
piggyBac transposable element-derived protein 3-like
LOW QUALITY PROTEIN: inactive dipeptidyl peptidase 10-like
RNA-binding motif protein, Y chromosome, family 1 member F/J-like, transcript variant X3
uncharacterized protein LOC123510125 isoform X3
RNA-binding motif protein, Y chromosome, family 1 member F/J-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
RNA-binding motif protein, Y chromosome, family 1 member F/J-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RNA-binding motif protein, Y chromosome, family 1 member F/J-like isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cold and drought-regulated protein CORA-like
glycine-rich protein DOT1-like, transcript variant X2
glycine-rich protein DOT1-like, transcript variant X1
glycine-rich protein DOT1-like isoform X1
glycine-rich protein DOT1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
galactosylceramide sulfotransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein OPI10 homolog, transcript variant X3
protein OPI10 homolog, transcript variant X2
protein OPI10 homolog, transcript variant X1
U6 snRNA-associated Sm-like protein LSm3, transcript variant X2
U6 snRNA-associated Sm-like protein LSm3 isoform X2
U6 snRNA-associated Sm-like protein LSm3, transcript variant X1
chromatin accessibility complex protein 1-like isoform X1
transfer RNA isoleucine (anticodon UAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
leucine-rich repeat extensin-like protein 5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC123510234, transcript variant X1
uncharacterized LOC123510234, transcript variant X2
uncharacterized LOC123510234, transcript variant X4
uncharacterized LOC123510234, transcript variant X3
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
cilia- and flagella-associated protein 251-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
zinc finger and BTB domain-containing protein 47-like, transcript variant X2
zinc finger and BTB domain-containing protein 47-like, transcript variant X1
zinc finger and BTB domain-containing protein 47-like
uncharacterized LOC123510154, transcript variant X3
uncharacterized LOC123510154, transcript variant X1
uncharacterized LOC123510154, transcript variant X2
putative GATA zinc finger domain-containing protein 25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
MAP kinase-activating death domain protein-like, transcript variant X2
MAP kinase-activating death domain protein-like, transcript variant X5
MAP kinase-activating death domain protein-like, transcript variant X13
MAP kinase-activating death domain protein-like, transcript variant X1
MAP kinase-activating death domain protein-like, transcript variant X3
MAP kinase-activating death domain protein-like, transcript variant X8
MAP kinase-activating death domain protein-like, transcript variant X7
MAP kinase-activating death domain protein-like, transcript variant X12
MAP kinase-activating death domain protein-like, transcript variant X18
MAP kinase-activating death domain protein-like, transcript variant X15
MAP kinase-activating death domain protein-like, transcript variant X10
MAP kinase-activating death domain protein-like, transcript variant X16
MAP kinase-activating death domain protein-like, transcript variant X9
MAP kinase-activating death domain protein-like, transcript variant X14
MAP kinase-activating death domain protein-like, transcript variant X4
MAP kinase-activating death domain protein-like, transcript variant X20
MAP kinase-activating death domain protein-like, transcript variant X19
MAP kinase-activating death domain protein-like, transcript variant X6
MAP kinase-activating death domain protein-like, transcript variant X17
MAP kinase-activating death domain protein-like, transcript variant X11
MAP kinase-activating death domain protein-like isoform X4
MAP kinase-activating death domain protein-like isoform X15
MAP kinase-activating death domain protein-like isoform X9
MAP kinase-activating death domain protein-like isoform X6
MAP kinase-activating death domain protein-like isoform X5
MAP kinase-activating death domain protein-like isoform X18
MAP kinase-activating death domain protein-like isoform X17
MAP kinase-activating death domain protein-like isoform X10
MAP kinase-activating death domain protein-like isoform X16
MAP kinase-activating death domain protein-like isoform X13
MAP kinase-activating death domain protein-like isoform X8
MAP kinase-activating death domain protein-like isoform X3
MAP kinase-activating death domain protein-like isoform X14
MAP kinase-activating death domain protein-like isoform X7
MAP kinase-activating death domain protein-like isoform X12
MAP kinase-activating death domain protein-like isoform X11
MAP kinase-activating death domain protein-like isoform X2
MAP kinase-activating death domain protein-like isoform X1
dehydrogenase/reductase SDR family member 4-like
ATP synthase lipid-binding protein, mitochondrial-like
signal recognition particle receptor subunit alpha-like, transcript variant X1
signal recognition particle receptor subunit alpha-like, transcript variant X2
signal recognition particle receptor subunit alpha-like isoform X1
signal recognition particle receptor subunit alpha-like isoform X2
vacuolar protein sorting-associated protein 45-like, transcript variant X3
vacuolar protein sorting-associated protein 45-like, transcript variant X1
vacuolar protein sorting-associated protein 45-like, transcript variant X2
vacuolar protein sorting-associated protein 45-like
sodium-coupled neutral amino acid transporter 9-like
nuclear pore complex protein DDB_G0274915-like, transcript variant X1
nuclear pore complex protein DDB_G0274915-like, transcript variant X2
nuclear pore complex protein DDB_G0274915-like, transcript variant X4
nuclear pore complex protein DDB_G0274915-like, transcript variant X3
nuclear pore complex protein DDB_G0274915-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nuclear pore complex protein DDB_G0274915-like, transcript variant X5
nuclear pore complex protein DDB_G0274915-like isoform X1
nuclear pore complex protein DDB_G0274915-like isoform X2
uncharacterized protein LOC123510223 isoform X3
WD repeat-containing protein 48 homolog, transcript variant X3
WD repeat-containing protein 48 homolog, transcript variant X2
WD repeat-containing protein 48 homolog, transcript variant X1
WD repeat-containing protein 48 homolog, transcript variant X6
WD repeat-containing protein 48 homolog, transcript variant X4
WD repeat-containing protein 48 homolog, transcript variant X5
rap-GAP domain-containing protein DDB_G0281809-like isoform X3
DEP domain-containing protein DDB_G0279099-like isoform X2
DEP domain-containing protein DDB_G0279099-like isoform X1
rap-GAP domain-containing protein DDB_G0281809-like isoform X6
rap-GAP domain-containing protein DDB_G0281809-like isoform X4
WD repeat-containing protein 48 homolog isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
LOW QUALITY PROTEIN: V-type proton ATPase subunit C-like
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X9
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X2
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X8
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X13
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X10
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X5
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X4
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X15
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like, transcript variant X14
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X2
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X5
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X6
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X1
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X4
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X8
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X10
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X9
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X7
dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase-like isoform X3
uncharacterized LOC123510249, transcript variant X1
uncharacterized LOC123510249, transcript variant X2
uncharacterized LOC123510249, transcript variant X3
uncharacterized protein LOC123510249 isoform X1
uncharacterized protein LOC123510249 isoform X2
CDC42 small effector protein 2-A-like, transcript variant X3
CDC42 small effector protein 2-A-like, transcript variant X1
CDC42 small effector protein 2-A-like, transcript variant X2
heparan sulfate glucosamine 3-O-sulfotransferase 5-like, transcript variant X5
heparan sulfate glucosamine 3-O-sulfotransferase 5-like, transcript variant X7
heparan sulfate glucosamine 3-O-sulfotransferase 5-like, transcript variant X6
heparan sulfate glucosamine 3-O-sulfotransferase 5-like, transcript variant X3
heparan sulfate glucosamine 3-O-sulfotransferase 5-like, transcript variant X4
heparan sulfate glucosamine 3-O-sulfotransferase 5-like, transcript variant X2
heparan sulfate glucosamine 3-O-sulfotransferase 5-like, transcript variant X1
heparan sulfate glucosamine 3-O-sulfotransferase 5-like isoform X4
heparan sulfate glucosamine 3-O-sulfotransferase 5-like isoform X1
heparan sulfate glucosamine 3-O-sulfotransferase 5-like isoform X2
heparan sulfate glucosamine 3-O-sulfotransferase 5-like isoform X3
protein TRACHEARY ELEMENT DIFFERENTIATION-RELATED 7A-like
probable chitinase 10, transcript variant X1
probable chitinase 10, transcript variant X3
probable chitinase 10, transcript variant X4
probable chitinase 10, transcript variant X2
probable chitinase 10, transcript variant X5
rab GTPase-binding effector protein 1-like, transcript variant X4
rab GTPase-binding effector protein 1-like, transcript variant X3
rab GTPase-binding effector protein 1-like, transcript variant X2
rab GTPase-binding effector protein 1-like, transcript variant X1
rab GTPase-binding effector protein 1-like, transcript variant X5
rab GTPase-binding effector protein 1-like, transcript variant X6
rab GTPase-binding effector protein 1-like isoform X3
rab GTPase-binding effector protein 1-like isoform X2
rab GTPase-binding effector protein 1-like isoform X1
rab GTPase-binding effector protein 1-like isoform X4
rab GTPase-binding effector protein 1-like isoform X5
glutenin, high molecular weight subunit DX5-like
uncharacterized LOC123510227, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123510227, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
centromere/kinetochore protein zw10 homolog, transcript variant X2
centromere/kinetochore protein zw10 homolog, transcript variant X1
centromere/kinetochore protein zw10 homolog
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X8
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X14
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X13
IQ motif and SEC7 domain-containing protein 1-like isoform X8
IQ motif and SEC7 domain-containing protein 1-like isoform X13
IQ motif and SEC7 domain-containing protein 1-like isoform X14
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X7
IQ motif and SEC7 domain-containing protein 1-like isoform X7
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X9
IQ motif and SEC7 domain-containing protein 1-like isoform X9
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X11
IQ motif and SEC7 domain-containing protein 1-like isoform X11
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X10
IQ motif and SEC7 domain-containing protein 1-like isoform X10
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X3
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X4
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X2
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X1
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X6
IQ motif and SEC7 domain-containing protein 1-like isoform X1
IQ motif and SEC7 domain-containing protein 1-like isoform X2
IQ motif and SEC7 domain-containing protein 1-like isoform X4
IQ motif and SEC7 domain-containing protein 1-like isoform X3
IQ motif and SEC7 domain-containing protein 1-like isoform X6
IQ motif and SEC7 domain-containing protein 1-like isoform X5
IQ motif and SEC7 domain-containing protein 1-like, transcript variant X12
IQ motif and SEC7 domain-containing protein 1-like isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments
calcium-activated chloride channel regulator 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium-activated chloride channel regulator 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium-activated chloride channel regulator 1-like isoform X2
calcium-activated chloride channel regulator 1-like isoform X1
uncharacterized LOC123510024, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized protein LOC123510024 isoform X1
uncharacterized LOC123510024, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
uncharacterized LOC123510024, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123510024, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC123510024, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized LOC123510024, transcript variant X2
uncharacterized protein LOC123510024 isoform X2
uncharacterized LOC123510024, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123510024, transcript variant X3
uncharacterized protein LOC123510024 isoform X3
uncharacterized LOC123510024, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized protein LOC123510024 isoform X4
uncharacterized LOC123510024, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC123510024 isoform X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: G-protein coupled receptor GRL101-like
serine/threonine-protein kinase PRP4 homolog
LOW QUALITY PROTEIN: serine/threonine-protein kinase PRP4 homolog
translocation protein SEC63 homolog, transcript variant X1
translocation protein SEC63 homolog, transcript variant X3
translocation protein SEC63 homolog, transcript variant X2
translocation protein SEC63 homolog, transcript variant X4
translocation protein SEC63 homolog, transcript variant X5
translocation protein SEC63 homolog isoform X1
translocation protein SEC63 homolog isoform X3
translocation protein SEC63 homolog isoform X2
translocation protein SEC63 homolog isoform X4
translocation protein SEC63 homolog isoform X5
anti-lipopolysaccharide factor-like, transcript variant X2
anti-lipopolysaccharide factor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 56 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
basic salivary proline-rich protein 2-like
glycine-rich cell wall structural protein-like
uncharacterized LOC123510132, transcript variant X1
uncharacterized LOC123510132, transcript variant X2
uncharacterized protein LOC123510132 isoform X1
uncharacterized protein LOC123510132 isoform X2
organic solute transporter subunit alpha-like, transcript variant X1
organic solute transporter subunit alpha-like, transcript variant X3
organic solute transporter subunit alpha-like, transcript variant X2
organic solute transporter subunit alpha-like isoform X1
SET domain-containing protein SmydA-8-like
SET domain-containing protein SmydA-8-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
SET domain-containing protein SmydA-8-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
SET domain-containing protein SmydA-8-like isoform X1
SET domain-containing protein SmydA-8-like isoform X2
SET domain-containing protein SmydA-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
histone-lysine N-methyltransferase ASHR1-like, transcript variant X2
histone-lysine N-methyltransferase ASHR1-like, transcript variant X1
histone-lysine N-methyltransferase ASHR1-like isoform X1
histone-lysine N-methyltransferase ASHR1-like isoform X2
organic solute transporter subunit alpha-like isoform X2
uncharacterized LOC123510031, transcript variant X1
uncharacterized LOC123510031, transcript variant X4
uncharacterized LOC123510031, transcript variant X3
uncharacterized LOC123510031, transcript variant X5
uncharacterized LOC123510031, transcript variant X2
uncharacterized protein LOC123510031 isoform X1
uncharacterized protein LOC123510031 isoform X3
uncharacterized protein LOC123510031 isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X3
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like, transcript variant X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X2
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like isoform X3
elongation factor 1-delta-like, transcript variant X3
elongation factor 1-delta-like, transcript variant X1
elongation factor 1-delta-like, transcript variant X2
elongation factor 1-delta-like, transcript variant X5
elongation factor 1-delta-like, transcript variant X4
elongation factor 1-delta-like, transcript variant X7
elongation factor 1-delta-like, transcript variant X6
elongation factor 1-delta-like isoform X1
elongation factor 1-beta'-like isoform X3
elongation factor 1-beta'-like isoform X4
elongation factor 1-beta-like isoform X7
elongation factor 1-beta'-like isoform X2
elongation factor 1-beta-like isoform X5
elongation factor 1-delta-like isoform X6
glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1-like
vicilin-like seed storage protein At2g18540
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 78% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123510075, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123510075, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC123510075 isoform X1
uncharacterized protein LOC123510075 isoform X2
uncharacterized LOC123510076, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC123510076, transcript variant X1
integrin-linked protein kinase-like, transcript variant X1
integrin-linked protein kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 5 long SRA reads, 4 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
protein Star-like, transcript variant X2
protein Star-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
protein Star-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
uncharacterized protein LOC123510077 isoform X2
uncharacterized LOC123510081, transcript variant X1
uncharacterized LOC123510081, transcript variant X2
uncharacterized LOC123510081, transcript variant X3
uncharacterized LOC123510083, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123510083, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123510083, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123510083, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123510083, transcript variant X5
uncharacterized LOC123510083, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123510080, transcript variant X1
uncharacterized LOC123510080, transcript variant X4
uncharacterized LOC123510080, transcript variant X2
uncharacterized LOC123510080, transcript variant X3
uncharacterized LOC123510091, transcript variant X1
uncharacterized LOC123510091, transcript variant X2
uncharacterized protein LOC123510091 isoform X2
uncharacterized protein LOC123510091 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123510087
uncharacterized LOC123510086, transcript variant X1
uncharacterized LOC123510086, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
protein madd-4-like, transcript variant X5
protein madd-4-like, transcript variant X4
protein madd-4-like, transcript variant X6
protein madd-4-like, transcript variant X9
protein madd-4-like, transcript variant X3
protein madd-4-like, transcript variant X10
protein madd-4-like, transcript variant X8
protein madd-4-like, transcript variant X7
protein madd-4-like, transcript variant X1
protein madd-4-like, transcript variant X2
protein madd-4-like, transcript variant X15
protein madd-4-like, transcript variant X14
protein madd-4-like, transcript variant X13
protein madd-4-like, transcript variant X12
protein madd-4-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 long SRA reads, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein madd-4-like, transcript variant X16
complement C1q tumor necrosis factor-related protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein KIAA1841 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
uncharacterized LOC123510253, transcript variant X2
uncharacterized LOC123510253, transcript variant X1
sphingolipid delta(4)-desaturase DES1-like
decapping and exoribonuclease protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
basement membrane-specific heparan sulfate proteoglycan core protein-like isoform X1
uncharacterized protein LOC123510295 isoform X2
uncharacterized LOC123510033, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123510033, transcript variant X1
uncharacterized LOC123510033, transcript variant X4
uncharacterized LOC123510033, transcript variant X3
uncharacterized LOC123510033, transcript variant X12
uncharacterized LOC123510033, transcript variant X8
uncharacterized LOC123510033, transcript variant X2
uncharacterized LOC123510033, transcript variant X9
uncharacterized LOC123510033, transcript variant X11
uncharacterized LOC123510033, transcript variant X10
uncharacterized LOC123510033, transcript variant X5
uncharacterized LOC123510033, transcript variant X7
uncharacterized LOC123510033, transcript variant X6
uncharacterized LOC123510033, transcript variant X14
uncharacterized LOC123510033, transcript variant X16
uncharacterized LOC123510033, transcript variant X15
uncharacterized LOC123510033, transcript variant X19
uncharacterized LOC123510033, transcript variant X18
uncharacterized LOC123510033, transcript variant X17
uncharacterized LOC123510033, transcript variant X20
uncharacterized protein LOC123510033 isoform X1
uncharacterized protein LOC123510033 isoform X4
uncharacterized protein LOC123510033 isoform X3
uncharacterized protein LOC123510033 isoform X12
uncharacterized protein LOC123510033 isoform X8
uncharacterized protein LOC123510033 isoform X2
uncharacterized protein LOC123510033 isoform X9
uncharacterized protein LOC123510033 isoform X11
uncharacterized protein LOC123510033 isoform X10
uncharacterized protein LOC123510033 isoform X5
uncharacterized protein LOC123510033 isoform X14
uncharacterized protein LOC123510033 isoform X19
uncharacterized protein LOC123510033 isoform X7
uncharacterized protein LOC123510033 isoform X16
uncharacterized protein LOC123510033 isoform X18
uncharacterized protein LOC123510033 isoform X6
uncharacterized protein LOC123510033 isoform X15
uncharacterized protein LOC123510033 isoform X17
uncharacterized protein LOC123510033 isoform X20
uncharacterized protein LOC123510033 isoform X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC123510130, transcript variant X2
uncharacterized LOC123510130, transcript variant X1
uncharacterized protein LOC123510130 isoform X1
uncharacterized protein LOC123510130 isoform X2
uncharacterized LOC123510326, transcript variant X14
uncharacterized LOC123510326, transcript variant X17
uncharacterized LOC123510326, transcript variant X22
uncharacterized LOC123510326, transcript variant X18
uncharacterized LOC123510326, transcript variant X12
uncharacterized LOC123510326, transcript variant X11
uncharacterized LOC123510326, transcript variant X13
uncharacterized LOC123510326, transcript variant X16
uncharacterized LOC123510326, transcript variant X19
uncharacterized LOC123510326, transcript variant X21
uncharacterized protein LOC123510326 isoform X10
uncharacterized protein LOC123510326 isoform X11
uncharacterized protein LOC123510326 isoform X13
uncharacterized protein LOC123510326 isoform X14
uncharacterized protein LOC123510326 isoform X16
uncharacterized LOC123510326, transcript variant X10
uncharacterized protein LOC123510326 isoform X9
uncharacterized LOC123510326, transcript variant X1
uncharacterized LOC123510326, transcript variant X2
uncharacterized LOC123510326, transcript variant X4
uncharacterized LOC123510326, transcript variant X5
uncharacterized LOC123510326, transcript variant X3
uncharacterized LOC123510326, transcript variant X6
uncharacterized protein LOC123510326 isoform X1
uncharacterized protein LOC123510326 isoform X2
uncharacterized protein LOC123510326 isoform X4
uncharacterized protein LOC123510326 isoform X5
uncharacterized protein LOC123510326 isoform X3
uncharacterized protein LOC123510326 isoform X6
uncharacterized LOC123510326, transcript variant X20
uncharacterized protein LOC123510326 isoform X15
uncharacterized LOC123510326, transcript variant X7
uncharacterized LOC123510326, transcript variant X9
uncharacterized LOC123510326, transcript variant X15
uncharacterized LOC123510326, transcript variant X8
uncharacterized protein LOC123510326 isoform X7
uncharacterized protein LOC123510326 isoform X8
uncharacterized protein LOC123510326 isoform X12
uncharacterized LOC123510326, transcript variant X23
uncharacterized LOC123510326, transcript variant X24
uncharacterized LOC123510326, transcript variant X25
uncharacterized protein LOC123510326 isoform X17
uncharacterized protein LOC123510326 isoform X18
uncharacterized protein LOC123510326 isoform X19
exocyst complex component 5-like, transcript variant X1
exocyst complex component 5-like isoform X1
exocyst complex component 5-like, transcript variant X2
exocyst complex component 5-like isoform X2
histone-lysine N-methyltransferase SETMAR-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
semaphorin-1A-like, transcript variant X2
semaphorin-1A-like, transcript variant X7
semaphorin-1A-like, transcript variant X5
semaphorin-1A-like, transcript variant X3
semaphorin-1A-like, transcript variant X6
semaphorin-1A-like, transcript variant X4
semaphorin-1A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123510134, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC123510134, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC123510134 isoform X2
uncharacterized protein LOC123510134 isoform X1
galactose-3-O-sulfotransferase 4-like, transcript variant X2
galactose-3-O-sulfotransferase 4-like, transcript variant X1
galactose-3-O-sulfotransferase 4-like isoform X1
galactose-3-O-sulfotransferase 4-like isoform X2
galactose-3-O-sulfotransferase 4-like, transcript variant X4
galactose-3-O-sulfotransferase 4-like, transcript variant X5
galactose-3-O-sulfotransferase 4-like, transcript variant X3
galactose-3-O-sulfotransferase 4-like isoform X4
galactosylceramide sulfotransferase-like isoform X1
galactosylceramide sulfotransferase-like isoform X2
galactosylceramide sulfotransferase-like isoform X3
galactosylceramide sulfotransferase-like isoform X5
nuclear protein localization protein 4 homolog, transcript variant X1
nuclear protein localization protein 4 homolog, transcript variant X2
nuclear protein localization protein 4 homolog isoform X1
nuclear protein localization protein 4 homolog isoform X2
trichohyalin-like, transcript variant X1
trichohyalin-like, transcript variant X4
trichohyalin-like, transcript variant X3
trichohyalin-like, transcript variant X2
bromodomain-containing protein DDB_G0280777-like
uncharacterized protein C19orf47 homolog, transcript variant X2
uncharacterized protein C19orf47 homolog, transcript variant X3
uncharacterized protein C19orf47 homolog, transcript variant X1
uncharacterized protein C19orf47 homolog isoform X2
uncharacterized protein C19orf47 homolog isoform X1
AP-4 complex subunit epsilon-1-like, transcript variant X1
AP-4 complex subunit epsilon-1-like, transcript variant X2
AP-4 complex subunit epsilon-1-like isoform X1
AP-4 complex subunit epsilon-1-like isoform X2
acetylcholine receptor subunit alpha-like, transcript variant X4
acetylcholine receptor subunit alpha-like isoform X3
acetylcholine receptor subunit alpha-like, transcript variant X3
acetylcholine receptor subunit alpha-like, transcript variant X1
acetylcholine receptor subunit alpha-like, transcript variant X2
acetylcholine receptor subunit alpha-like isoform X1
acetylcholine receptor subunit alpha-like isoform X2
tubulin beta chain, transcript variant X2
tubulin beta chain, transcript variant X1
cyclin-dependent kinase 9-like, transcript variant X1
cyclin-dependent kinase 9-like, transcript variant X2
cyclin-dependent kinase 9-like isoform X1
cyclin-dependent kinase 9-like isoform X2
leucine-rich repeat protein soc-2 homolog
luc7-like protein 3, transcript variant X3
luc7-like protein 3, transcript variant X1
luc7-like protein 3, transcript variant X2
protein CREBRF homolog, transcript variant X6
protein CREBRF homolog, transcript variant X2
protein CREBRF homolog, transcript variant X3
protein CREBRF homolog, transcript variant X5
protein CREBRF homolog, transcript variant X1
protein CREBRF homolog, transcript variant X4
uncharacterized LOC123510043, transcript variant X4
uncharacterized LOC123510043, transcript variant X7
uncharacterized LOC123510043, transcript variant X1
uncharacterized LOC123510043, transcript variant X5
uncharacterized LOC123510043, transcript variant X3
uncharacterized LOC123510043, transcript variant X2
uncharacterized LOC123510043, transcript variant X6
uncharacterized LOC123510043, transcript variant X8
uncharacterized protein LOC123510043 isoform X2
uncharacterized protein LOC123510043 isoform X1
uncharacterized protein LOC123510043 isoform X4
uncharacterized protein LOC123510043 isoform X3
uncharacterized protein LOC123510043 isoform X5
uncharacterized LOC123510042, transcript variant X1
uncharacterized LOC123510042, transcript variant X3
uncharacterized LOC123510042, transcript variant X2
uncharacterized LOC123510042, transcript variant X4
uncharacterized protein LOC123510042 isoform X1
uncharacterized protein LOC123510042 isoform X3
uncharacterized protein LOC123510042 isoform X2
uncharacterized protein LOC123510042 isoform X4
tetraspanin-13-like, transcript variant X1
tetraspanin-13-like, transcript variant X2
DNA topoisomerase 2-binding protein 1-like
methionine--tRNA ligase, mitochondrial-like, transcript variant X3
methionine--tRNA ligase, mitochondrial-like, transcript variant X6
methionine--tRNA ligase, mitochondrial-like, transcript variant X1
methionine--tRNA ligase, mitochondrial-like, transcript variant X5
methionine--tRNA ligase, mitochondrial-like, transcript variant X2
methionine--tRNA ligase, mitochondrial-like, transcript variant X7
methionine--tRNA ligase, mitochondrial-like, transcript variant X4
methionine--tRNA ligase, mitochondrial-like
limbic system-associated membrane protein-like, transcript variant X1
limbic system-associated membrane protein-like, transcript variant X2
limbic system-associated membrane protein-like isoform X1
limbic system-associated membrane protein-like isoform X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B-like, transcript variant X3
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B-like, transcript variant X1
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B-like, transcript variant X4
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B-like, transcript variant X2
serine/threonine-protein phosphatase 6 regulatory ankyrin repeat subunit B-like
elongation factor Tu-like, transcript variant X4
elongation factor Tu-like, transcript variant X1
elongation factor Tu-like, transcript variant X2
elongation factor Tu-like, transcript variant X3
beta-1 adrenergic receptor-like, transcript variant X2
beta-1 adrenergic receptor-like, transcript variant X3
beta-1 adrenergic receptor-like, transcript variant X4
beta-1 adrenergic receptor-like, transcript variant X1
beta-1 adrenergic receptor-like isoform X2
transmembrane protein 198-like, transcript variant X1
transmembrane protein 198-like, transcript variant X3
transmembrane protein 198-like, transcript variant X2
transmembrane protein 198-like, transcript variant X4
transmembrane protein 198-like isoform X1
transmembrane protein 198-like isoform X2
probable phosphorylase b kinase regulatory subunit beta, transcript variant X2
probable phosphorylase b kinase regulatory subunit beta, transcript variant X3
probable phosphorylase b kinase regulatory subunit beta, transcript variant X8
probable phosphorylase b kinase regulatory subunit beta, transcript variant X9
probable phosphorylase b kinase regulatory subunit beta, transcript variant X10
probable phosphorylase b kinase regulatory subunit beta, transcript variant X6
probable phosphorylase b kinase regulatory subunit beta, transcript variant X1
probable phosphorylase b kinase regulatory subunit beta, transcript variant X5
probable phosphorylase b kinase regulatory subunit beta, transcript variant X7
probable phosphorylase b kinase regulatory subunit beta, transcript variant X11
probable phosphorylase b kinase regulatory subunit beta, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit beta, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
probable phosphorylase b kinase regulatory subunit beta isoform X2
probable phosphorylase b kinase regulatory subunit beta isoform X3
probable phosphorylase b kinase regulatory subunit beta isoform X8
probable phosphorylase b kinase regulatory subunit beta isoform X9
probable phosphorylase b kinase regulatory subunit beta isoform X10
probable phosphorylase b kinase regulatory subunit beta isoform X6
probable phosphorylase b kinase regulatory subunit beta isoform X1
probable phosphorylase b kinase regulatory subunit beta isoform X5
probable phosphorylase b kinase regulatory subunit beta isoform X7
probable phosphorylase b kinase regulatory subunit beta isoform X11
probable phosphorylase b kinase regulatory subunit beta isoform X12
probable phosphorylase b kinase regulatory subunit beta isoform X13
probable phosphorylase b kinase regulatory subunit beta, transcript variant X4
probable phosphorylase b kinase regulatory subunit beta isoform X4
transforming growth factor-beta receptor-associated protein 1-like
uncharacterized LOC123510137, transcript variant X1
uncharacterized LOC123510137, transcript variant X2
cysteine-rich with EGF-like domain protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC123510265, transcript variant X3
uncharacterized LOC123510265, transcript variant X2
uncharacterized LOC123510265, transcript variant X1
phospholipase ABHD3-like, transcript variant X1
phospholipase ABHD3-like, transcript variant X4
phospholipase ABHD3-like, transcript variant X5
phospholipase ABHD3-like, transcript variant X3
phospholipase ABHD3-like, transcript variant X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1
LOW QUALITY PROTEIN: SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A-like protein 1
serine/threonine-protein kinase mTOR-like, transcript variant X2
serine/threonine-protein kinase mTOR-like, transcript variant X1
serine/threonine-protein kinase mTOR-like isoform X2
serine/threonine-protein kinase mTOR-like isoform X1
glycine dehydrogenase (decarboxylating), mitochondrial-like
LOW QUALITY PROTEIN: glycine dehydrogenase (decarboxylating), mitochondrial-like
purine nucleoside phosphorylase-like, transcript variant X2
purine nucleoside phosphorylase-like, transcript variant X1
purine nucleoside phosphorylase-like isoform X2
purine nucleoside phosphorylase-like isoform X1
LOW QUALITY PROTEIN: 14-3-3 protein epsilon-like
uncharacterized LOC123510277, transcript variant X1
uncharacterized LOC123510277, transcript variant X2
uncharacterized protein LOC123510277 isoform X1
uncharacterized protein LOC123510277 isoform X2
succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein split ends-like
KN motif and ankyrin repeat domain-containing protein 2-like
uncharacterized LOC123510274, transcript variant X2
uncharacterized LOC123510274, transcript variant X5
uncharacterized LOC123510274, transcript variant X4
uncharacterized LOC123510274, transcript variant X3
uncharacterized LOC123510274, transcript variant X1
uncharacterized protein LOC123510274 isoform X4
uncharacterized protein LOC123510274 isoform X3
uncharacterized protein LOC123510274 isoform X2
uncharacterized protein LOC123510274 isoform X1
E3 ubiquitin-protein ligase RNF181-like, transcript variant X4
E3 ubiquitin-protein ligase RNF181-like, transcript variant X2
E3 ubiquitin-protein ligase RNF181-like, transcript variant X1
E3 ubiquitin-protein ligase RNF181-like, transcript variant X3
proline-rich extensin-like protein EPR1, transcript variant X2
proline-rich extensin-like protein EPR1, transcript variant X1
mitochondrial folate transporter/carrier-like
probable serine/threonine-protein kinase DDB_G0280133, transcript variant X1
probable serine/threonine-protein kinase DDB_G0280133, transcript variant X3
probable serine/threonine-protein kinase DDB_G0280133, transcript variant X2
uncharacterized protein LOC123510276 isoform X1
uncharacterized protein LOC123510276 isoform X3
uncharacterized protein LOC123510276 isoform X2
probable serine/threonine-protein kinase DDB_G0280133, transcript variant X5
probable serine/threonine-protein kinase DDB_G0280133, transcript variant X4
probable serine/threonine-protein kinase DDB_G0280133 isoform X5
probable serine/threonine-protein kinase DDB_G0280133 isoform X4
28S ribosomal protein S18b, mitochondrial-like, transcript variant X2
28S ribosomal protein S18b, mitochondrial-like, transcript variant X3
28S ribosomal protein S18b, mitochondrial-like, transcript variant X1
28S ribosomal protein S18b, mitochondrial-like isoform X2
28S ribosomal protein S18b, mitochondrial-like isoform X1
28S ribosomal protein S18b, mitochondrial-like isoform X3
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X1
serine/threonine-protein phosphatase 1 regulatory subunit 10-like, transcript variant X2
serine/threonine-protein phosphatase 1 regulatory subunit 10-like isoform X1
serine/threonine-protein phosphatase 1 regulatory subunit 10-like isoform X2
uncharacterized LOC123510291, transcript variant X8
uncharacterized LOC123510291, transcript variant X6
uncharacterized LOC123510291, transcript variant X2
uncharacterized LOC123510291, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC123510291, transcript variant X11
uncharacterized LOC123510291, transcript variant X4
uncharacterized LOC123510291, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC123510291, transcript variant X5
uncharacterized LOC123510291, transcript variant X3
uncharacterized LOC123510291, transcript variant X9
uncharacterized LOC123510291, transcript variant X10
uncharacterized LOC123510293, transcript variant X4
uncharacterized LOC123510293, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123510293, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123510293, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
N-acetylated-alpha-linked acidic dipeptidase 2-like, transcript variant X1
N-acetylated-alpha-linked acidic dipeptidase 2-like, transcript variant X2
N-acetylated-alpha-linked acidic dipeptidase 2-like
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
organic cation transporter protein-like, transcript variant X1
organic cation transporter protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123510207, transcript variant X1
uncharacterized LOC123510207, transcript variant X3
uncharacterized LOC123510207, transcript variant X2
uncharacterized LOC123510207, transcript variant X4
uncharacterized LOC123510207, transcript variant X11
uncharacterized LOC123510207, transcript variant X5
uncharacterized LOC123510207, transcript variant X13
uncharacterized LOC123510207, transcript variant X9
uncharacterized LOC123510207, transcript variant X7
uncharacterized LOC123510207, transcript variant X6
uncharacterized LOC123510207, transcript variant X12
uncharacterized LOC123510207, transcript variant X10
uncharacterized LOC123510207, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X5
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X1
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X2
glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1-like isoform X3
uncharacterized LOC123510107, transcript variant X2
uncharacterized LOC123510107, transcript variant X3
uncharacterized LOC123510107, transcript variant X1
uncharacterized protein LOC123510107 isoform X1
uncharacterized protein LOC123510107 isoform X2
uncharacterized protein LOC123510107 isoform X3
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like
LOW QUALITY PROTEIN: phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like, transcript variant X1
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like, transcript variant X2
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like, transcript variant X3
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like isoform X1
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like isoform X2
phosphoenolpyruvate carboxykinase, cytosolic [GTP]-like isoform X3
methylosome subunit pICln-like, transcript variant X1
methylosome subunit pICln-like, transcript variant X3
methylosome subunit pICln-like, transcript variant X2
methylosome subunit pICln-like, transcript variant X4
methylosome subunit pICln-like isoform X4
methylosome subunit pICln-like isoform X3
methylosome subunit pICln-like isoform X2
methylosome subunit pICln-like isoform X1
GPI ethanolamine phosphate transferase 3-like
LOW QUALITY PROTEIN: GPI ethanolamine phosphate transferase 3-like
host cell factor 2-like, transcript variant X2
host cell factor 2-like, transcript variant X3
host cell factor 2-like, transcript variant X1
host cell factor 2-like, transcript variant X4
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X6
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X8
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X2
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X13
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X4
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X7
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X12
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X10
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X9
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X5
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X3
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like, transcript variant X11
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X5
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X4
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X1
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X3
N-fatty-acyl-amino acid synthase/hydrolase PM20D1-like isoform X2
progesterone-induced-blocking factor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
progesterone-induced-blocking factor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
progesterone-induced-blocking factor 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
progesterone-induced-blocking factor 1-like isoform X2
progesterone-induced-blocking factor 1-like isoform X1
progesterone-induced-blocking factor 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
progesterone-induced-blocking factor 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
progesterone-induced-blocking factor 1-like isoform X3
uncharacterized LOC123510138, transcript variant X1
uncharacterized LOC123510138, transcript variant X3
uncharacterized LOC123510138, transcript variant X4
uncharacterized LOC123510138, transcript variant X2
uncharacterized LOC123510141, transcript variant X2
uncharacterized LOC123510141, transcript variant X1
anionic trypsin-like, transcript variant X2
anionic trypsin-like, transcript variant X1
anionic trypsin-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
RNA-binding protein NOB1-like, transcript variant X2
RNA-binding protein NOB1-like, transcript variant X3
RNA-binding protein NOB1-like, transcript variant X4
RNA-binding protein NOB1-like, transcript variant X5
RNA-binding protein NOB1-like, transcript variant X1
RNA-binding protein NOB1-like, transcript variant X6
RNA-binding protein NOB1-like isoform X1
RNA-binding protein NOB1-like isoform X3
RNA-binding protein NOB1-like isoform X2
uncharacterized LOC123510148, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123510148, transcript variant X2
uncharacterized LOC123510148, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC123509987, transcript variant X2
uncharacterized LOC123509987, transcript variant X1
uncharacterized protein LOC123509987 isoform X1
uncharacterized protein LOC123509987 isoform X2
uncharacterized LOC123509990, transcript variant X3
uncharacterized LOC123509990, transcript variant X1
uncharacterized LOC123509990, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
macrophage migration inhibitory factor homolog
fasciclin-2-like, transcript variant X11
fasciclin-2-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized serine-rich protein C215.13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
acid-sensing ion channel 2-like, transcript variant X1
acid-sensing ion channel 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SRSF protein kinase 1-like, transcript variant X7
SRSF protein kinase 1-like, transcript variant X5
SRSF protein kinase 1-like, transcript variant X3
SRSF protein kinase 1-like, transcript variant X2
SRSF protein kinase 1-like, transcript variant X6
SRSF protein kinase 1-like, transcript variant X1
SRSF protein kinase 1-like, transcript variant X4
SRSF protein kinase 1-like, transcript variant X8
mediator of DNA damage checkpoint protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
LOW QUALITY PROTEIN: mediator of DNA damage checkpoint protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
histidine--tRNA ligase, cytoplasmic-like, transcript variant X1
histidine--tRNA ligase, cytoplasmic-like, transcript variant X2
histidine--tRNA ligase, cytoplasmic-like, transcript variant X3
histidine--tRNA ligase, cytoplasmic-like, transcript variant X4
histidine--tRNA ligase, cytoplasmic-like isoform X3
histidine--tRNA ligase, cytoplasmic-like isoform X1
histidine--tRNA ligase, cytoplasmic-like isoform X2
histidine--tRNA ligase, cytoplasmic-like isoform X4
LOW QUALITY PROTEIN: pituitary homeobox 2-like
importin subunit alpha-3-like, transcript variant X2
importin subunit alpha-3-like, transcript variant X3
importin subunit alpha-3-like, transcript variant X4
importin subunit alpha-3-like, transcript variant X1
importin subunit alpha-3-like, transcript variant X5
importin subunit alpha-3-like, transcript variant X6
importin subunit alpha-3-like, transcript variant X7
vesicle-associated membrane protein 7-like, transcript variant X1
vesicle-associated membrane protein 7-like, transcript variant X3
vesicle-associated membrane protein 7-like, transcript variant X2
vesicle-associated membrane protein 7-like, transcript variant X4
vesicle-associated membrane protein 7-like
neuropeptide F-like, transcript variant X4
neuropeptide F-like, transcript variant X2
neuropeptide F-like, transcript variant X1
neuropeptide F-like, transcript variant X3
uncharacterized protein LOC123510254 isoform X2
uncharacterized protein LOC123510254 isoform X1
uncharacterized protein LOC123510254 isoform X3
transfer RNA alanine (anticodon AGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
60S ribosomal protein L44-like, transcript variant X1
60S ribosomal protein L44-like, transcript variant X2
60S ribosomal protein L44-like isoform X1
60S ribosomal protein L44-like isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: uncharacterized protein LOC123510060
AP2-associated protein kinase 1-like, transcript variant X1
AP2-associated protein kinase 1-like, transcript variant X3
AP2-associated protein kinase 1-like, transcript variant X2
AP2-associated protein kinase 1-like, transcript variant X4
uncharacterized protein LOC123510020 isoform X2
AP2-associated protein kinase 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
LOW QUALITY PROTEIN: uncharacterized protein LOC123510163
putative phosphatidate phosphatase, transcript variant X1
putative phosphatidate phosphatase, transcript variant X2
putative phosphatidate phosphatase isoform X1
phospholipid phosphatase 1-like isoform X2
putative phosphatidate phosphatase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
phospholipid phosphatase 1-like isoform X3
oxysterol-binding protein-related protein 8-like, transcript variant X4
oxysterol-binding protein-related protein 8-like, transcript variant X7
oxysterol-binding protein-related protein 8-like, transcript variant X8
oxysterol-binding protein-related protein 8-like, transcript variant X1
oxysterol-binding protein-related protein 8-like, transcript variant X3
oxysterol-binding protein-related protein 8-like, transcript variant X11
oxysterol-binding protein-related protein 8-like, transcript variant X2
oxysterol-binding protein-related protein 8-like, transcript variant X16
oxysterol-binding protein-related protein 8-like, transcript variant X5
oxysterol-binding protein-related protein 8-like isoform X1
oxysterol-binding protein-related protein 8-like isoform X3
oxysterol-binding protein-related protein 8-like isoform X10
oxysterol-binding protein-related protein 8-like isoform X2
oxysterol-binding protein-related protein 8-like isoform X14
oxysterol-binding protein-related protein 8-like isoform X4
oxysterol-binding protein-related protein 8-like isoform X7
oxysterol-binding protein-related protein 8-like isoform X8
oxysterol-binding protein-related protein 8-like isoform X5
oxysterol-binding protein-related protein 8-like, transcript variant X6
oxysterol-binding protein-related protein 8-like, transcript variant X17
oxysterol-binding protein-related protein 8-like isoform X6
oxysterol-binding protein-related protein 8-like isoform X15
oxysterol-binding protein-related protein 8-like, transcript variant X12
oxysterol-binding protein-related protein 8-like, transcript variant X15
oxysterol-binding protein-related protein 8-like, transcript variant X13
oxysterol-binding protein-related protein 8-like, transcript variant X14
oxysterol-binding protein-related protein 8-like, transcript variant X9
oxysterol-binding protein-related protein 8-like, transcript variant X18
oxysterol-binding protein-related protein 8-like, transcript variant X10
oxysterol-binding protein-related protein 8-like isoform X9
oxysterol-binding protein-related protein 8-like isoform X16
oxysterol-binding protein-related protein 8-like isoform X12
oxysterol-binding protein-related protein 8-like isoform X11
oxysterol-binding protein-related protein 8-like isoform X13
uncharacterized LOC123510109, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123510109, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized LOC123510109, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
uncharacterized LOC123510109, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123510109, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123510109, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X3
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
glucose dehydrogenase [FAD, quinone]-like isoform X3
glucose dehydrogenase [FAD, quinone]-like isoform X2
glucose dehydrogenase [FAD, quinone]-like isoform X1
UDP-glucose:glycoprotein glucosyltransferase 1-like, transcript variant X4
UDP-glucose:glycoprotein glucosyltransferase 1-like, transcript variant X5
UDP-glucose:glycoprotein glucosyltransferase 1-like, transcript variant X2
UDP-glucose:glycoprotein glucosyltransferase 1-like isoform X2
UDP-glucose:glycoprotein glucosyltransferase 1-like, transcript variant X1
UDP-glucose:glycoprotein glucosyltransferase 1-like, transcript variant X3
UDP-glucose:glycoprotein glucosyltransferase 1-like isoform X1
UDP-glucose:glycoprotein glucosyltransferase 1-like isoform X3
UDP-glucose:glycoprotein glucosyltransferase 1-like isoform X4
protein Wnt-11b-like, transcript variant X2
protein Wnt-11b-like, transcript variant X1
probable ATP-dependent RNA helicase DDX10, transcript variant X3
probable ATP-dependent RNA helicase DDX10, transcript variant X1
probable ATP-dependent RNA helicase DDX10, transcript variant X2
probable ATP-dependent RNA helicase DDX10, transcript variant X4
probable ATP-dependent RNA helicase DDX10, transcript variant X5
probable ATP-dependent RNA helicase DDX10
nucleoside diphosphate-linked moiety X motif 17-like, transcript variant X1
nucleoside diphosphate-linked moiety X motif 17-like, transcript variant X4
nucleoside diphosphate-linked moiety X motif 17-like, transcript variant X2
nucleoside diphosphate-linked moiety X motif 17-like, transcript variant X3
nucleoside diphosphate-linked moiety X motif 17-like, transcript variant X5
nucleoside diphosphate-linked moiety X motif 17-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
eukaryotic translation initiation factor 4E-binding protein 1-like
uncharacterized LOC123510167, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123510167, transcript variant X1
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC123510167, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC123510167, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123510167, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123510167, transcript variant X3
uncharacterized LOC123510167, transcript variant X6
uncharacterized LOC123510167, transcript variant X7
BTB/POZ domain-containing protein 6-like, transcript variant X2
BTB/POZ domain-containing protein 6-like, transcript variant X3
BTB/POZ domain-containing protein 6-like, transcript variant X1
BTB/POZ domain-containing protein 6-like isoform X1
BTB/POZ domain-containing protein 6-like isoform X2
threonylcarbamoyladenosine tRNA methylthiotransferase-like
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X8
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X3
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X1
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X7
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X6
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X9
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X4
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X5
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X10
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like, transcript variant X2
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like isoform X1
protein-L-isoaspartate(D-aspartate) O-methyltransferase-like isoform X2
cleavage and polyadenylation specificity factor subunit 1-like, transcript variant X3
cleavage and polyadenylation specificity factor subunit 1-like, transcript variant X2
cleavage and polyadenylation specificity factor subunit 1-like, transcript variant X1
cleavage and polyadenylation specificity factor subunit 1-like
cilia- and flagella-associated protein 251-like, transcript variant X2
cilia- and flagella-associated protein 251-like, transcript variant X1
cilia- and flagella-associated protein 251-like isoform X2
ecotropic viral integration site 5 ortholog-like, transcript variant X3
ecotropic viral integration site 5 ortholog-like, transcript variant X4
ecotropic viral integration site 5 ortholog-like, transcript variant X5
ecotropic viral integration site 5 ortholog-like isoform X3
ecotropic viral integration site 5 ortholog-like isoform X4
ecotropic viral integration site 5 ortholog-like isoform X5
ecotropic viral integration site 5 ortholog-like, transcript variant X2
ecotropic viral integration site 5 ortholog-like isoform X2
ecotropic viral integration site 5 ortholog-like, transcript variant X1
ecotropic viral integration site 5 ortholog-like, transcript variant X8
ecotropic viral integration site 5 ortholog-like isoform X1
ecotropic viral integration site 5 ortholog-like isoform X7
ecotropic viral integration site 5 ortholog-like, transcript variant X11
ecotropic viral integration site 5 ortholog-like isoform X10
ecotropic viral integration site 5 ortholog-like, transcript variant X10
ecotropic viral integration site 5 ortholog-like isoform X9
ecotropic viral integration site 5 ortholog-like, transcript variant X9
ecotropic viral integration site 5 ortholog-like isoform X8
ecotropic viral integration site 5 ortholog-like, transcript variant X7
ecotropic viral integration site 5 ortholog-like, transcript variant X6
ecotropic viral integration site 5 ortholog-like isoform X6
uncharacterized LOC123510017, transcript variant X1
uncharacterized LOC123510017, transcript variant X2
uncharacterized LOC123510298, transcript variant X1
uncharacterized LOC123510298, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC123510298, transcript variant X2
uncharacterized LOC123510298, transcript variant X4